Article Details
Retrieved on: 2024-04-18 19:00:37
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Monoclonal antibodies emerged as the top revenue-generating product, commanding a 44% share of the market in 2023. Gene therapy products are ...
Article found on: www.biospace.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here